Introduction
1. Glucose kinetics were assessed in seven normal adult male subjects by an intravenous bolus technique with the use of a non-radioactive isotopically labelled preparation, [6,6-2Hlglucose, as tracer. Tracer enrichment in plasma was assessed by gas chromatography-mass spectrometry. For comparison five subjects also received a simultaneous intravenous bolus of [6-3Hlglucose and kinetics were assessed by conventional means.
2. Administration of [6,6-*H]glucose did not alter circulating glucose or insulin concentrations.
3. Glucose turnover, assessed by the use of [6,6-2Hlglucose, was 11.4 (f0-9) pmol min-' kg-' and 11.6 (f0.5) pmol min-' kg-' with [6-3Hlglucose. The mean metabolic clearance rate of glucose was 2.3 (f0.3) ml min-' kg-' 
Methods

subjects andpro~oco~
Seven normal adult male volunteers (Table 1) Correspondence: Dr D. G. Johnston, Endocrine ,Unit, Royal Victoria Infirmary, Newcastle upon Tyne NEl4LP, U.K.
were studied in the recumbent position after a 10 h overnight fast. Indwelling intravenous cannulae were positioned in opposite antecubital veins and kept patent by intermittent flushing with NaCl solution (0.154 mol/l).
Basal blood samples were taken, followed by a bolus intravenous injection, from a pre-weighed syringe, of 100-400 mg of [6,6-2H]glucose in 2 ml of sterile water. [6,6-ZHlGlucose was obtained from Merck, Sharp and Dohme (Canada) Ltd (Montreal, Que., Canada) and dissolved to a concentration of 100 mg/ml in pyrogen-free water before being sealed in glass ampoules and sterilized by autoclave. Blanks run in parallel were checked for pyrogenicity and sterility. The syringe was re-weighed after injection. Isotopic purity was checked by mass spectrometry.
Five subjects also received a simultaneous intravenous bolus of 50 pCi of [6-3Hlglucose (The Radiochemical Centre, Amersham, Bucks., U.K.). Blood samples for determination of serum insulin (2 ml), blood glucose (1 ml), [6,6-'HIglucose enrichment (2 ml) and glucose specific activity (4 ml) were withdrawn at -30, -15,0, 2, 3, 4, 5 , 6, 8, 10, 12.5, 15, 20, 30, 40, 50, 60, 75, 90, 120, 150 and 180 min. This study was approved by the Ethical Committee of the Newcastle Area Health Authority (T), and informed consent was obtained from each subject.
Chemical methods
Blood for glucose determination was taken into 5 ml of chilled HC104 (0.5 mol/l) and assayed by an automated fluorimetric enzymic method [ 161. Blood for determination of glucose specific activity was taken into heparinized tubes, and the plasma was stored at -2OOC until assay. A 0-5 ml portion of plasma was deproteinized by adding 1 ml of Ba(OH), (0.15 mol/l), 1 ml of ZnSO, (0.17 mol/l) and 7.5 ml of distilled water. The supernatant was freeze-dried, resuspended in a toluene-based scintillant (cocktail T; Hopkin and Williams, Chadwell Heath, Essex, U.K.), and its radioactivity was counted in a scintillation counter (Intertechnique, St. Albans, Herts., U.K.), with an external standard to correct for efficiency.
Serum insulin was assayed by double-antibody radioimmunoassay [ 171. Blood for assessment of [6,6-2Hlglucose enrichment was deproteinized in 2 ml of sulphosalicylic acid (0-275 mol/l). After centrifugation at 2000 rev./min in an MSE Mistral 6L centrifuge for 20 min, the supernatant was neutrally deionized by shaking for 5 min with half its volume of the ion-exchange resin Duolite DMF (BDH Chemicals Ltd, Poole, Dorset, U.K.). The resin had previously been acetified by washing with acetic acid (4 mol/l) followed by 20 rinsings with deionized water. After centrifugation at 2000 rev./min for 5 min the second supernatant was freeze-dried overnight (Edwards model 30 P2/801 apparatus) and stored in sealed glass tubes within a silica-gel desiccator. Before chromatography the powder was treated with 50 pl of N-methylbis(trifluoroacetamide) [ system. The gas chromatography was run isothermally at 85°C on a packed 3% OV-17 Gas-Chrom Q column (100-120 mesh) with a helium flow rate of 20 ml/min and an injector temperature of 25OOC. The column elutions corresponding to a-and Pglucose, retention times 3.01 min and 3.50 min, were fed into the mass spectrometer and chemically ionized with methane. The ratio of the intensities of the positive ions 547 and 549 m/e was monitored with the mass spectrometer set in the selective ion-monitoring mode. Mass 547 ( M -1 13) represents pentatrifluoroacetylglucose minus a trifluoroacetate group. Ratios were assessed at the same section of the mass chromatogram peak on each occasion, and the average value from a-and P-glucose peaks was used for calculations. The basal ratio due to the natural abundance of heavy isotopes was subtracted.
Calculations
Specific activity and [6,6-2Hlglucose enrichment expressed as percentages were plotted against time. Doublelexponential functions were fitted to these curves by linear least-squares regression by using an iterative program on a minicomputer (Apple I1 Europlus, Apple Computer Inc., Cupertino, CA, U.S.A.). Values for glucose turnover, metabolic clearance rate, mean residence time, glucose pool and glucose space were calculated by standard techniques [6] .
Results
The mean fasting blood glucose concentration was 5.2 (f0.6) mmol 1-' and the mean fasting serum insulin concentration was 8.2 (k 1.1) munits 1-'. There was no measurable change in these values during the experiment. The correlation of curve fit for the double exponential decay of glucose specific activity vs time was 0.97 (0.94-0.98), and for [6,6-ZH21glucose enrichment vs time was 0.98 (0.89-0.99). The mean (~S E M ) glucose turnover in the five subjects who received both isotopically labelled tracers was 11.4 (f0-9) pmol min-I kg-I for [6,6-2Hlglucose and 11.6 (f0.5) pmol mh-I kg-I for [6-'HIglucose. The mean (~S E M ) metabolic clearance rate in the same subjects was 2.3 (f0.3) ml min-' kg-' for both isotopic labels (Table 1) . Glucose pool, space and mean residence time were similar with each isotopic label.
The coefficient of variation for the measurement of [6,6-2Hlglucose enrichment by the g.c.-m.s. system was 1.09% at high enrichment ratios (5.79%) and 1.66% at low enrichment ratios (3.15%). Many workers with non-radioactive isotopically labelled tracers have used isotope-ratio gas-analyser mass spectrometers to monitor '3C-labelled glucose [ 10-121, but sample handling is cumbersome and I3C labels (like I4C labels) are recycled and can thus underestimate turnover [20, 211. The combination of g.c.-m.s. and 2H labels avoids these problems, but this technique has often necessitated large doses of injected tracer per kg body wt. [13-151, which may upset the steady state [141. Our study used relatively small doses of [6,6-*HIglucose, and these had no observable effect on serum insulin or blood glucose concentrations.
Discussion
[6,6-2HlGlucose therefore satisfies the three requirements of an ideal tracer. It is detectable in sufficiently low concentrations that its use does not disturb the steady state, there is no metabolic discrimination between it and its non-labelled counterpart, and it has no known direct or accumulative harmful effects. This last property is its principal advantage over radioactive tracers.
